#ChatsWIthChaudhrey interviews Jeffrey Silva, director of product development, Adeptrix Corporation

Jeffrey explained how BAMS™ Assay Platform simplifies the process for targeted- and discovery-based proteomic applications, by replacing the need for liquidchromatography separation methods in the analysis of complex biological samples by utilizing affinity enrichment (e.g. antibody-based) directed to specific target proteins, prior to MS analysis.

Run time: 17:36 mins

#ChatsWIthChaudhrey Interviews Jeffrey Silva, Director of Product Development, Adeptrix Corporation

Video Credit: Bruker Life Sciences Mass Spectrometry

Other Videos by this Supplier